These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35689323)

  • 1. Letter: non-selective beta-blockers in cirrhosis-effect beyond portal hypertension.
    Chauhan A; Bhatia A
    Aliment Pharmacol Ther; 2022 Jul; 56(1):184-185. PubMed ID: 35689323
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: non-selective beta-blockers in cirrhosis-effect beyond portal hypertension. Authors' reply.
    Dunne P; Young D; Chuah CS; Hayes P; Tripathi D; Leithead J; Smith L; Gaya D; Forrest E; Stanley AJ
    Aliment Pharmacol Ther; 2022 Jul; 56(1):186-187. PubMed ID: 35689317
    [No Abstract]   [Full Text] [Related]  

  • 3. Beta adrenergic blockade and decompensated cirrhosis.
    Reiberger T; Mandorfer M
    J Hepatol; 2017 Apr; 66(4):849-859. PubMed ID: 27864004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of ß-blocker therapy to prevent primary bleeding of esophageal varices.
    Tursi T
    J Am Acad Nurse Pract; 2010 Dec; 22(12):640-7. PubMed ID: 21129071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Beta-blockers in portal hypertension: Unexpected limitations!].
    Thevenot T; Cervoni JP; Di Martino V
    Presse Med; 2011 Mar; 40(3):227-9. PubMed ID: 21093210
    [No Abstract]   [Full Text] [Related]  

  • 6. Beta-blockers to prevent gastroesophageal varices in cirrhosis.
    Post AB
    N Engl J Med; 2006 Mar; 354(12):1318-20; author reply 1318-20. PubMed ID: 16554538
    [No Abstract]   [Full Text] [Related]  

  • 7. Beta-blockers for prophylaxis of bleeding from esophageal varices in cirrhotic portal hypertension. Review of the literature.
    Zoller WG; Gross M
    Eur J Med Res; 1996 Jun; 1(9):407-16. PubMed ID: 9353240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NONSELECTIVE BETA-BLOCKERS IN PATIENTS WITH CIRRHOSIS: "THE THERAPEUTIC WINDOW".
    Dimache M; Gîrleanu I; Carpov E; Trifan A; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(1):23-8. PubMed ID: 27125068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blockers to prevent esophageal varices--an unfulfilled promise.
    Mukherjee S; Sorrell MF
    N Engl J Med; 2005 Nov; 353(21):2288-90. PubMed ID: 16306528
    [No Abstract]   [Full Text] [Related]  

  • 10. Nonselective Beta-Blockers in Compensated Cirrhosis: Preventing Variceal Hemorrhage or Preventing Decompensation?
    Garcia-Tsao G; Abraldes JG
    Gastroenterology; 2021 Sep; 161(3):770-773. PubMed ID: 33989660
    [No Abstract]   [Full Text] [Related]  

  • 11. Beta-receptor blocking treatment in portal hypertension.
    Olsson R
    Scand J Gastroenterol; 1990 Jul; 25(7):641-6. PubMed ID: 1975704
    [No Abstract]   [Full Text] [Related]  

  • 12. Preventing the development of varices in cirrhosis.
    Garcia-Tsao G
    J Clin Gastroenterol; 2007; 41 Suppl 3():S300-4. PubMed ID: 17975480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and future pharmacological therapies for managing cirrhosis and its complications.
    Kockerling D; Nathwani R; Forlano R; Manousou P; Mullish BH; Dhar A
    World J Gastroenterol; 2019 Feb; 25(8):888-908. PubMed ID: 30833797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic prevention of variceal bleeding and rebleeding.
    Baiges A; Hernández-Gea V; Bosch J
    Hepatol Int; 2018 Feb; 12(Suppl 1):68-80. PubMed ID: 29210030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of non-selective beta blockers in cirrhosis: the evidence we need before closing (or not) the window.
    La Mura V; Tosetti G; Primignani M; Salerno F
    World J Gastroenterol; 2015 Feb; 21(8):2265-8. PubMed ID: 25741132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-blockers in cirrhosis: Do they have benefits beyond the prevention of variceal bleeding?
    Selvan S; Aggarwal R
    Natl Med J India; 2019; 32(6):355-356. PubMed ID: 33380631
    [No Abstract]   [Full Text] [Related]  

  • 17. [Adrenergic beta blockade in liver cirrhosis with portal hypertension? Doppler ultrasound measurement of the short-term effect of propranolol on the portal system].
    Wruck U; Wermke W
    Z Arztl Fortbild (Jena); 1992 Apr; 86(7-8):371-5. PubMed ID: 1615718
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of non-selective beta blockers on portal hypertension and hepatic elasticity in hepatitis C virus-related liver cirrhosis.
    Zaghloul SG; Wahab EA; Seleem WM; Hanafy AS; Gomaa AF; Lakouz K; Amin AI
    Drug Discov Ther; 2019; 13(2):108-113. PubMed ID: 31080201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The longitudinal outcomes of applying non-selective beta-blockers in portal hypertension: real-world multicenter study.
    Kang SH; Lee M; Kim MY; Lee JH; Jun BG; Kim TS; Choi DH; Suk KT; Kim YD; Cheon GJ; Kim DJ; Baik SK
    Hepatol Int; 2021 Apr; 15(2):424-436. PubMed ID: 33860898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications.
    Korean Association for the Study of the Liver (KASL)
    Clin Mol Hepatol; 2020 Apr; 26(2):83-127. PubMed ID: 31918536
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.